CMC Biologics' Acquisition

CMC Biologics was acquired by AGC Asahi Glass on December 19, 2016.

CMC Biologics, fka CMC Biopharmaceuticals, is a global contract process development and manufacturer of monoclonal antibodies, coagulation factors, and other therapeutic proteins. The Company has expe…

Articles about CMC Biologics' Acquisition: